Key result
Panax ginseng and its active components demonstrate therapeutic potential against atherosclerosis by modulating inflammatory pathways, inhibiting platelet aggregation, and preventing thrombus formation.
Why the study?
The detailed correlation between platelet aggregation and innate immunity in cardiovascular disease progression has not been thoroughly summarized.
This review highlights the potential of Panax ginseng and its active components as therapeutic agents against atherosclerosis through the inhibition of inflammation, platelet aggregation, and thrombus formation.
Ginseng may offer adjunctive CVD benefits; leaves open efficacy confirmation in randomized trials before clinical adoption.
Ginseng has been widely studied due to its various therapeutic properties on various diseases such as cardiovascular disease (CVD). Cardiovascular disease has been canonically known to be caused by high levels of low-density lipoproteins (LDL) in the bloodstream, in addition to the impaired vasodilatory effects of cholesterol. However, current research on CVD has revealed a cascade of mechanisms involving a series of events that contribute to the progression of CVD. Although this has been elucidated and summarized in previous studies the detailed correlation between platelet aggregation and innate immunity that plays an important role in CVD progression has not been thoroughly summarized. Furthermore, immune cell subtypes also contribute to the progression of plaque formation in the subendothelial layer. Thrombus formation and the coagulation cascade also have a vital role in the progression of atherosclerosis. Hence, in this mini review we aim to elucidate, summarize, and propose the potent therapeutic effect of ginseng on CVD, mainly on platelet aggregation, plaque formation, and thrombus formation.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2021) conducted a review in Atherosclerosis and Cardiovascular Disease. Panax ginseng was evaluated. Panax ginseng and its active components demonstrate therapeutic potential against atherosclerosis by modulating inflammatory pathways, inhibiting platelet aggregation, and preventing thrombus formation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: